Release date：2023-03-23
The blind sample testing work for the mutual recognition of test results in Beijing-Tianjin-Hebei-Shandong in 2023, organized by the Beijing Medical Laboratory Quality Control and Improvement Center, was launched on March 22. BDH Group, as requested by the organizers, completed the preparation and distribution of samples for the first blind sample testing work in 2023.
Preparation Work
Preparation Work
This sample preparation covers a total of 55 test items, including routine chemistry, tumor markers, endocrinology, special proteins, viral hepatitis, glycated hemoglobin, coagulation factors, and blood cell counts. To ensure the quality of the test results, these samples were delivered to the participating laboratories the same evening.
Distribution Work
Yesterday afternoon at 3 p.m., the preparation and distribution of blind sample testing samples for this round were successfully completed, marking BDH Group’s eighth consecutive completion of blind sample preparation work. BDH Group’s technical staff, with their professionalism and rigor, completed the blind sample preparation and distribution work in a timely manner and with high quality, receiving high recognition from the Beijing Medical Laboratory Quality Control and Improvement Center leadership.
BDH Group has long been committed to the research, development, and production of IVD products, continuously providing high-quality products and services to the field of medical testing.
